{"date":"2025-07-04","count":15,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1795-2025-07-04-1858-1m8t5fg","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-07-04","time":"18:58:32","subject":"(補充111/10/17公告)代重要子公司公告遭韓國公平交易委員會處以罰鍰事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-07-04 18:58，「(補充111/10/17公告)代重要子公司公告遭韓國公平交易委員會處以罰鍰事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-07-04-1754-b9wopg","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-07-04","time":"17:54:09","subject":"公告本公司取得簽證會計師內部控制專案審查報告(審查期間113/04/01至114/03/31)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-07-04 17:54，「公告本公司取得簽證會計師內部控制專案審查報告(審查期間113/04/01至114/03/31)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2025-07-04-1717-o0ne4b","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2025-07-04","time":"17:17:13","subject":"公告本公司董事會決議除權息基準日相關事宜","clause":"第31款","fact_date":"2025-07-04","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2025-07-04 17:17，「公告本公司董事會決議除權息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2025-07-04-1653-xcis2a","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2025-07-04","time":"16:53:18","subject":"本公司為子公司提供背書保證，依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第一款申報事項","clause":"第22款","fact_date":"2025-07-04","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2025-07-04 16:53，「本公司為子公司提供背書保證，依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第一款申報事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2025-07-04-1651-uxtlhs","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2025-07-04","time":"16:51:42","subject":"公告本公司董事會決議除權息基準日","clause":"第14款","fact_date":"2025-07-04","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2025-07-04 16:51，「公告本公司董事會決議除權息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-07-04-1518-16h9ko2","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-07-04","time":"15:18:54","subject":"公告本公司董事會決議召開114年第二次股東臨時會相關事宜","clause":"第32款","fact_date":"2025-07-04","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-07-04 15:18，「公告本公司董事會決議召開114年第二次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-04-1516-j3x6xz","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-04","time":"15:16:58","subject":"代子公司Chemix Inc.公告董事會選任董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-04 15:16，「代子公司Chemix Inc.公告董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-04-1516-1u9kodi","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-04","time":"15:16:42","subject":"代子公司Chemix Inc.公告法人代表異動事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-04 15:16，「代子公司Chemix Inc.公告法人代表異動事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-04-1515-1q3am7b","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-04","time":"15:15:56","subject":"代子公司Chemix Inc.公告2025年第一次臨時股東會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-04 15:15，「代子公司Chemix Inc.公告2025年第一次臨時股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2025-07-04-1515-dg2rxg","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2025-07-04","time":"15:15:30","subject":"代子公司Chemix Inc.公告董事會決議召開2025年第一次臨時股東大會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永信（3705），2025-07-04 15:15，「代子公司Chemix Inc.公告董事會決議召開2025年第一次臨時股東大會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2025-07-04-1453-16g7qjx","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2025-07-04","time":"14:53:25","subject":"公告本公司初次申請股票上市時所出具之承諾事項暨其後續執行情形","clause":"第51款","fact_date":"2025-07-04","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2025-07-04 14:53，「公告本公司初次申請股票上市時所出具之承諾事項暨其後續執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2025-07-04-1449-1ewxucf","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2025-07-04","time":"14:49:23","subject":"公告本公司114年現金股利配息基準日","clause":"第14款","fact_date":"2025-07-04","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2025-07-04 14:49，「公告本公司114年現金股利配息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2025-07-04-0946-ac89kl","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2025-07-04","time":"09:46:12","subject":"公告本公司申請股票上櫃轉上市時所出具之承諾事項暨其後續執行情形","clause":"第51款","fact_date":"2025-07-04","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2025-07-04 09:46，「公告本公司申請股票上櫃轉上市時所出具之承諾事項暨其後續執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2025-07-04-0933-1qtka21","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2025-07-04","time":"09:33:00","subject":"公告本公司董事會選任副董事長","clause":"第6款","fact_date":"2015-07-04","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2025-07-04 09:33，「公告本公司董事會選任副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2025-07-04-0828-75k6ol","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2025-07-04","time":"08:28:21","subject":"本公司公告Future Pak收購Theratechnologies不影響與本公司Trogarzo現有合作關係並持續穩固","clause":"第53款","fact_date":"2025-07-04","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2025-07-04 08:28，「本公司公告Future Pak收購Theratechnologies不影響與本公司Trogarzo現有合作關係並持續穩固」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}